An Aerts

Person

Aerts, An

Person

  1. Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumour

    Geenen, L., Nonnekens, J., Konijnenberg, M. W., Baatout, S., de Jong, M. & Aerts, A., 1 Nov 2021, In: Nuclear Medicine and Biology. 102-103, p. 1-11 11 p.

    Research output: Contribution to journalArticlepeer-review

  2. Preclinical development of 698ga-labelled aptamers for molecular cancer imaging

    Gijs, M., Aerts, A., Impens, N. & Baatout, S., 17 Sep 2015, Liège, Belgium: ULg - Université de Liège. 181 p.

    Research output: ThesisDoctoral thesis

  3. Gallium-68-labelled NOTA-oligonucleotides - an optimized method for their preparation

    Gijs, M., Dammicco, S., Warnier, C., Aerts, A., Impens, N., D’Huyvetter, M., Léonard, M., Baatout, S. & Luxen, A., 1 Feb 2016, In: Journal of Labelled Compounds and Radiopharmaceuticals. 59, 2, p. 63-71 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

    Gijs, M., Penner, G., Blackler, G. B., Impens, N., Baatout, S., Luxen, A. & Aerts, A., 15 May 2016, In: Pharmaceuticals. 9, 2, 29.

    Research output: Contribution to journalArticlepeer-review

  5. Aptamers as radiopharmaceuticals for nuclear imaging and therapy

    Gijs, M., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 15 Apr 2016, In: Nuclear Medicine and Biology.

    Research output: Contribution to journalArticlepeer-review

  6. Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice

    Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 11 Aug 2016, In: Journal of Nuclear Medicine and Radiation Therapy. 7, 5, 8 p., 1000300.

    Research output: Contribution to journalArticlepeer-review

  7. Ionizing radiation biomarkers in epidemiological studies – An update

    Hall, J., Jeggo, P., West, C., Gomolka, M., Quintens, R., Badie, C., Laurent, O., Aerts, A., Anastasov, N., Azimzadeh, O., Azizova, T., Baatout, S., Baselet, B., Benotmane, R., Blanchardon, E., Gueguen, Y., Haghdoost, S., Harms-Ringhdahl, M., Hess, J., Kreuzer, M., Laurier, D., Macaeva, E., Manning, G., Pernot, E., Ravanat, J-L., Sabatier, L., Tack, K., Tapio, S., Zitzelsberger, H. & Cardis, E., 16 Jan 2017, In: Mutation Research/Reviews in Mutation Research. 771, p. 59-84 26 p.

    Research output: Contribution to journalArticlepeer-review

  8. The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far

    Heynickx, N., Herrmann, K., Vermeulen, K., Baatout, S. & Aerts, A., 2021, In: Nuclear Medicine and Biology. 98-99, p. 30-39 10 p.

    Research output: Contribution to journalArticlepeer-review

  9. PRECLINICAL RESEARCH AND SYSTEMATIC PRODUCTION OF INNOVATIVE MEDICAL RADIO-ISOTOPES AT ISOL@MYRRHA

    Popescu, L., Pauwels, D., Aerts, A., Aït Abderrahim, H., Baatout, S., Baeten, P., Gijs, M., Huyse, M., Impens, N., Neyens, G., Raabe, R., Severijns, N., Schuurmans, P., Schyns, M., Temst, K., Van Duppen, P., Vantomme, A. & Wagemans, J., Mar 2012, In: Radiotherapy & Oncology Journal. 102, 1, p. 111-111

    Research output: Contribution to journalArticlepeer-review

  10. SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis

    Put, S., Schoonooghe, S., Devoogdt, N., Schurgers, E., Avau, A., Mitera, T., D'huyvetter, M., De Baetselier, P., Raes, G., Lahoutte, T., Matthys, P., Baatout, S., Aerts, A. & Impens, N., 27 Feb 2013, In: Journal of Nuclear Medicine. 54, 5, p. 807-814

    Research output: Contribution to journalArticlepeer-review

ID: 39219